1,688 search results for “shared cell differentiatie” in the Public website
-
Cees van KootenISSC
-
Loek ter LaakISSC
-
Auke VisserASSC
-
Wim van den BergISSC
-
Nick van Tuijn-BoogmansASSC
-
Rolf BoonISSC
-
Angélique van der LeeuwISSC
-
Casper de RooijISSC
-
Peter MagielseASSC
-
Jeroen RuiterASSC
-
Bryan SepersISSC
-
Trudi Blomsma-PetersAdministration and Central Services
-
Sandra Holster-de RuijterASSC
-
Paul van der ElstISSC
-
Robert van LeeuwenISSC
-
Julian van der KraatsISSC
-
Jozien van AkkerISSC
-
Ezra DijkstraISSC
-
Mark van LeeuwenISSC
-
Edith den BoerASSC
-
Annemieke HoogenboezemASSC
-
Wendy van Duijn-OudshoornASSC
-
Chi Leung WongISSC
-
John Islam-van KlinkenISSC
-
Martijn van NoortISSC
-
Frank GubbelsASSC
-
Jeen van NoortISSC
-
Sandra Sipkema-de JongASSC
-
Chantal Zuiderwijk-KockASSC
-
Peter WelterISSC
-
Rowena van der ReijdenASSC
-
Iris von SchmidASSC
-
Leonora van HemertASSC
-
Johan VazelISSC
-
Jennifer van der MeijISSC
-
Leiden University honours Lex van der Eb with University Medal
Leiden University has awarded its prestigious University Medal to Emeritus Professor Lex van der Eb. As a pioneer in genetics and molecular biology, he received this honour for his services to science and his key role in the development of the Leiden Bio Science Park (LBSP).
-
Daphny Ulje-KouerASSC
-
A new target in the fight against Tuberculosis: exploring key enzymes in TB-causing bacteria
How do lipases in Mycobacterium tuberculosis help the bacteria survive, and can we target them to create new antibiotics?
-
Cancer and heredity
Some people are predisposed to develop cancer. Mutations in genetic material that increase a person’s chances of developing cancer can already be present at birth. Researchers are closely examining these mutations to learn more about how cancer begins to develop.
-
Participants
The CMCB comprises research groups from the Institute of Biology Leiden (IBL), the Leiden Institute of Chemistry (LIC) and the Leiden University Medical Center (LUMC).
-
More effective blocking of CCR2 receptor
The discovery of new medicines is a tedious and lengthy process. On average, over 10,000 molecules need to be studied for one to become a drug and reach the patient. Part of that process are the very costly clinical trials in humans, and candidate drugs often fail due to side effects or lack of efficacy.…
-
NL-BioImaging AM
NL-BioImaging AM is a distributed research infrastructure aimed at promoting progress in the most cutting edge microscopy technologies and providing open access to these technologies to a broad community of academic and industrial users. All Netherlands bio(medical) microscopy centers participate.
-
Classical conditioning to improve immunotherapy in cancer
Can the conditioning paradigm be used for checkpoint inhibition cancer treatment?
-
Science for Society
By carrying out fundamental research and providing excellent education, universities become a breeding ground for innovation and entrepreneurship.
-
Research
Research at the MCBIM group is comprised of the following research themes:
-
Molecular Pharmacology
In this research group, headed by Laura Heitman, novel receptor concepts in drug discovery are studied, aiming to increase the effectivity of medicines. Many drugs act via so-called G protein-coupled receptors (GPCRs) and therefore our research is mainly focused on understanding and improving drug-receptor…
-
Metabolomics and Analytics Centre
The ambition of the Metabolomics and Analytics Centre led by Thomas Hankemeier is to develop innovative analytical strategies for metabolomics-driven health monitoring and systems biology studies. Understanding the intricate balance between health, disease and adaptation to challenges relies on the…
-
Protein condensates as Materials
We have recently discovered that there are biological proteins that phase separate out of solution much the way oil will de-mix from water (see movie). These form dense, liquid-like phases called protein condensates.
-
Research projects
An overview of research themes and projects at ABS.
-
Semi-artificial photosynthesis
Artificial photosynthesis aims to produce fuels from solar energy using chemical processes. In semi-artificial photosynthesis, a hybrid approach is taken using both chemical and biotechnology components. We are developing hybrid systems, coupling light-harvesting nanoparticles to redox-enzymes (oxidoreductases)…